Disarming CAR-Tregs with a clinical-stage natural product to supercharge CAR-T therapy

Bowen Li, Haoran Xu, Wenjun Zhang, Jing Yang · 2026

Read Disarming CAR-Tregs with a clinical-stage natural product to supercharge CAR-T therapy by Bowen Li, Haoran Xu, Wenjun Zhang, Jing Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13226132.txt.

Description

Bowen Li and three co-authors described in 2026 how to strip a brake from engineered cancer-killing cells. CAR-T therapy transformed care for blood cancers, yet about sixty percent of patients relapse. One cause: some infused cells turn regulatory, becoming CAR-Tregs that suppress their effector teammates with calming signals. As few as five percent of these cells can doom treatment in animal models.

Screening over 3,000 compounds surfaced a natural product from a traditional Chinese herb. At a clinic-ready dose it cut the regulatory share by about forty percent and sharpened killing, without harming cell health. Tracing its target with a tagged probe pointed to a surface receptor for adenosine. The compound is already at clinical stage for other uses.

Catalog record

CREATORBowen Li, Haoran Xu, Wenjun Zhang, Jing Yang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE10 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13226132

Browse the full library · About the Tower of Babel